Medlive’s HK$4.22 Billion Hong Kong IPO and Rule 144A/Regulation S Offering

Simpson Thacher and Maples and Calder advised Medlive Technology Co. on the deal. King & Wood Mallesons acted as the PRC legal counsel for the sponsors,…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Alejandro Girola

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here